Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre
Guangxin Li,1,* Ying Zhao,1,* Keren Li,2,* Shizhong Yang,2 Canhong Xiang,2 Jiyong Song,3 Yanmei Yang,1 Gong Li,1 Jiahong Dong2,4 1Department of Radiation Oncology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, People’s Republi...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-11-01
|
| Series: | Journal of Hepatocellular Carcinoma |
| Subjects: | |
| Online Access: | https://www.dovepress.com/effectiveness-and-safety-of-the-pd-1-inhibitor-lenvatinib-plus-radioth-peer-reviewed-fulltext-article-JHC |